Immediate Impact

49 hit
Sub-graph 1 of 24

Citing Papers

Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021
2025 Hit
Mitochondrial diseases: from molecular mechanisms to therapeutic advances
2025 Hit
2 intermediate papers

Works of Davide Poli being referenced

Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancer
2022
Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol
2019

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Davide Poli 383 255 105 54 48 17 479
Mutlu Cihan Dağlıoğlu 268 0.7× 190 0.7× 61 0.6× 28 0.5× 17 0.4× 27 410
W-M Hsu 287 0.7× 185 0.7× 75 0.7× 56 1.0× 125 2.6× 13 495
John Thygesen 331 0.9× 188 0.7× 108 1.0× 17 0.3× 22 0.5× 19 426
Jason L. Chien 376 1.0× 177 0.7× 35 0.3× 43 0.8× 27 0.6× 23 450
Jane-Ming Lin 342 0.9× 245 1.0× 27 0.3× 180 3.3× 16 0.3× 26 543
Paul Mitchell 241 0.6× 156 0.6× 13 0.1× 109 2.0× 37 0.8× 19 503
Karim F. Damji 390 1.0× 261 1.0× 72 0.7× 96 1.8× 98 2.0× 14 520
David T.W. Fei 242 0.6× 190 0.7× 113 1.1× 130 2.4× 4 0.1× 13 511
Javier Cáceres‐del‐Carpio 201 0.5× 113 0.4× 28 0.3× 317 5.9× 15 0.3× 22 498
Kazuhito Yoneda 365 1.0× 174 0.7× 16 0.2× 134 2.5× 11 0.2× 29 526

All Works

Loading papers...

Rankless by CCL
2026